Your session is about to expire
← Back to Search
Behavioral Intervention
care.coach Pilot for Bone Marrow Transplant
N/A
Waitlist Available
Led By Gregory Abel, MPH, MD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks
Awards & highlights
Study Summary
This trial will test if an avatar-based technology can improve outcomes for people admitted to the hospital for a transplant.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Modification of care.coach
Patient Retention
Secondary outcome measures
Patient Satisfaction Rate
Rate of Completion of the HCT Educational Modules
The Completion Rate Post-Pilot Survey
Trial Design
1Treatment groups
Experimental Treatment
Group I: care.coach PilotExperimental Treatment1 Intervention
The research study procedures include screening for eligibility, a brief call with a research assistant after tablet is given to subject, and a survey after a subject has completed the study.
3 consecutive cohorts of 6 RIC HCT patients each.
care.coach is a "human-in the-loop" conversational agent (avatar) used to interact and converse with patients through natural dialogue and text-to-speech software that is powered by a team of trained human staff, called health advocates. A subject uses the avatar for up to 3 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Care.Coach
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Dana-Farber Cancer InstituteLead Sponsor
1,080 Previous Clinical Trials
340,912 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,346 Total Patients Enrolled
Gregory Abel, MPH, MDPrincipal InvestigatorDana-Farber Cancer Institute
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have undergone a reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (HCT).Only certain healthcare professionals (such as DFCI/HCC HCT nurse navigators, inpatient HCT nurses, and HCT doctors and extenders) are allowed to participate in the study.You must be 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: care.coach Pilot
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger